Copyright
©The Author(s) 2015.
World J Gastroenterol. May 14, 2015; 21(18): 5668-5676
Published online May 14, 2015. doi: 10.3748/wjg.v21.i18.5668
Published online May 14, 2015. doi: 10.3748/wjg.v21.i18.5668
Figure 1 Quantitative changes in biochemical and virus markers in chronic hepatitis B patients after interferon therapy.
A: ALT levels; B: HBV DNA levels; C: HBsAg levels; D: HBeAg levels; E: Anti-HBc levels. ALT: Alanine aminotransferase; HBV: Hepatitis B virus; HBsAg: Hepatitis B surface antigen; HBeAg: Hepatitis B e antigen; anti-HBc: Antibody to hepatitis B core antigen.
- Citation: Wang CT, Zhang YF, Sun BH, Dai Y, Zhu HL, Xu YH, Lu MJ, Yang DL, Li X, Zhang ZH. Models for predicting hepatitis B e antigen seroconversion in response to interferon-α in chronic hepatitis B patients. World J Gastroenterol 2015; 21(18): 5668-5676
- URL: https://www.wjgnet.com/1007-9327/full/v21/i18/5668.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i18.5668